# Efficacy of Zoster Vaccination in Glioblastoma Patients

> **NCT07546669** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University Hospital, Essen** · enrollment: 230 (estimated)

## Conditions studied

- Glioblastoma (GBM)

## Interventions

- **BIOLOGICAL:** Additional vaccination against shingles (herpes zoster)
- **OTHER:** Standard of care treatment without additional vaccination

## Key facts

- **NCT ID:** NCT07546669
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-02
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07546669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07546669, "Efficacy of Zoster Vaccination in Glioblastoma Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07546669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*